DermaGen completes patient enrollment in phase I/IIa trial of antimicrobial peptide DPK-060 July 9, 2009
BL-5010 scheduled to begin phase I/II clinical trial in nonsurgical removal of skin lesions June 22, 2009
Cis-urocanic acid emulsion improves skin barrier function in acute irritant dermatitis phase I study June 15, 2009